SYNOVUS FINANCIAL CORP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$92,160
+33.3%
48,0000.0%0.00%0.0%
Q2 2023$69,120
-31.4%
48,0000.0%0.00%0.0%
Q1 2023$100,800
+85.8%
48,0000.0%0.00%0.0%
Q4 2022$54,240
-30.5%
48,0000.0%0.00%0.0%
Q3 2022$78,000
+23.8%
48,0000.0%0.00%0.0%
Q2 2022$63,000
-18.2%
48,0000.0%0.00%0.0%
Q1 2022$77,000
-22.2%
48,0000.0%0.00%0.0%
Q4 2021$99,00048,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders